Neoadjuvant Intra-tumor Double Immunotherapy for Hepatocellular Carcinoma.

Abroad (travel likely)RecruitingPHASE2

Conditions

Hepatic Cancer · Surgery

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The Second Affiliated Hospital of Guangzhou Medical University, Guanzhou, Guangdong, China
Contact: Study coordinator (Zhenfeng Zhang, MD,PhD) · zhangzhf@gzhmu.edu.cn · 02034153532

Study leads

Zhenfeng Zhang, MD, PhD
Principal Investigator
Second Affiliated Hospital of Guangzhou Medical University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Cabozantinib Combined With Ipilimumab/Nivolumab and TACE in Patients With Hepatocellular Carcinoma

Hepatocellular Carcinoma · HCC

Abroad (travel likely)RecruitingPHASE2

Orange, United States

Durvalumab With/Without Tremelimumab After Palliative Hypofractionated Radiotherapy for Hepatocellular Carcinoma

Advanced Hepatocellular Carcinoma · Stage III Hepatocellular Carcinoma AJCC v8 · Stage IIIA Hepatocellular Carcinoma AJCC v8

Abroad (travel likely)RecruitingPHASE2

San Francisco, United States